Skip to main content
Guttmacher Institute

Search

  • X
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
  • Contact

Highlights

  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • US policy resources
  • State policy resources
  • International Perspectives on Sexual and Reproductive Health (1975–2020)
  • Perspectives on Sexual and Reproductive Health (1969–2020)

Reports

  • Global
  • United States

Articles

  • Global research
  • US research
  • Policy analysis
  • Guttmacher Policy Review
  • Opinion

Fact Sheets

  • Global
  • United States
  • US State Laws and Policies

Tools

  • Interactive Map: US Abortion Policies and Access After Roe
  • Family Planning Investment Impact Calculator
  • Monthly Abortion Provision Study Dashboard
  • State legislation tracker
  • Public-use data sets

Global

  • Abortion
  • Contraception
  • Pregnancy
  • Teens

US

  • Abortion
  • Contraception
  • Pregnancy
  • Teens

Our Work by Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • Newsletter
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Ways to Give
  • Guttmacher Guardians
  • Guttmacher Legacy Circle
  • Financials
  • Impact Report 2025

Awards & Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship
Donate
Guttmacher Institute
Donate

Highlights

  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • US policy resources
  • State policy resources
  • International Perspectives on Sexual and Reproductive Health (1975–2020)
  • Perspectives on Sexual and Reproductive Health (1969–2020)

Reports

  • Global
  • United States

Articles

  • Global research
  • US research
  • Policy analysis
  • Guttmacher Policy Review
  • Opinion

Fact Sheets

  • Global
  • United States
  • US State Laws and Policies

Tools

  • Interactive Map: US Abortion Policies and Access After Roe
  • Family Planning Investment Impact Calculator
  • Monthly Abortion Provision Study Dashboard
  • State legislation tracker
  • Public-use data sets

Global

  • Abortion
  • Contraception
  • Pregnancy
  • Teens

US

  • Abortion
  • Contraception
  • Pregnancy
  • Teens

Our Work by Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • Newsletter
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Ways to Give
  • Guttmacher Guardians
  • Guttmacher Legacy Circle
  • Financials
  • Impact Report 2025

Awards & Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship
Donate
  • X
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
  • Contact

Principal Research Scientist

Rachel K. Jones

Portrait of Rachel Jones

Rachel Jones has worked at the Guttmacher Institute since 1999. She received her PhD in sociology from Tulane University, where she studied gender, family and inequality. Since 2000, she has been the principal investigator for the Institute’s national studies of U.S. abortion patients, and she has overseen the U.S. Abortion Provider Census since 2008. Dr. Jones is considered a leading expert on abortion in the United States. She has also conducted studies on contraceptive use, health insurance and adolescent sexual health in the United States, using both qualitative and quantitative data. Dr. Jones is a member of the American Public Health Association and the Population Association of America, and she serves on the board of directors of the National Abortion Federation.

Download CV
All Staff

Selected Publications

  1. Medication Abortion
    March 2024 Policy Analysis

    Eight Key Points to Consider as the US Supreme Court Weighs in on Medication Abortion

    Kelly Baden, Rachel K. Jones and Isabel Guarnieri
  2. February 2024 Opinion

    Why a Flawed Study on Medication Abortion Was Retracted

    Rachel K. Jones and Kelly Baden The Hill
  3. Preview image of a hospital Title X cascading harms policy analysis
    February 2024 Research Article

    Medicaid's role in alleviating some of the financial burden of abortion: Findings from the 2021–2022 Abortion Patient Survey

    Rachel K. Jones Perspectives on Sexual and Reproductive Health (University of Ottawa)
  4. Medication Abortion
    February 2024 Policy Analysis

    Medication Abortion Within and Outside the Formal US Health Care System: What You Need to Know

    Amy Friedrich-Karnik, Emma Stoskopf-Ehrlich and Rachel K. Jones
  5. An outline of the United States
    September 2023 Policy Analysis

    New State Abortion Data Indicate Widespread Travel for Care

    Isaac Maddow-Zimet, Kelly Baden, Rachel K. Jones, Isabel DoCampo and Jesse Philbin
  6. Black and white text that reads "Abortion patient survey, medication vs. procedural abortion"
    August 2023 Research Article

    Characteristics of people obtaining medication versus procedural abortions in clinical settings in the United States: Findings from the 2021–2022 Abortion Patient Survey

    Rachel K. Jones, Doris W. Chiu and Julia E. Kohn Contraception
  7. A pride-rainbow background with writing: "Abortion patient survey"
    June 2023 Policy Analysis

    As Many as 16% of People Having Abortions Do Not Identify as Heterosexual Women

    Doris W. Chiu, Emma Stoskopf-Ehrlich and Rachel K. Jones
  8. April 2023 Research Article

    Characteristics of abortion patients in protected and restricted states accessing clinic-based care 12 months prior to the elimination of the federal constitutional right to abortion in the United States

    Rachel K. Jones and Doris W. Chiu Perspectives on Sexual and Reproductive Health (University of Ottawa)
  9. February 2023 Policy Analysis

    10 US States Would Be Hit Especially Hard by a Nationwide Ban on Medication Abortion Using Mifepristone

    Jesse Philbin, Rachel K. Jones, Emma Stoskopf-Ehrlich and Joerg Dreweke
  10. November 2022 Research Article

    Abortion incidence and service availability in the United States, 2020

    Rachel K. Jones, Marielle Kirstein and Jesse Philbin Perspectives on Sexual and Reproductive Health (University of Ottawa)

Pagination

  • First page First
  • Previous page Prev.
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next
  • Last page Last
Guttmacher Institute

Center facts. Shape policy.
Advance sexual and reproductive rights.®

Donate Now
Newsletter Signup  Contact Us 
  • X
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
  • Contact

Footer

  • Privacy Policy
  • Accessibility Statement
© 2025 Guttmacher Institute. The Guttmacher Institute is registered as a 501(c)(3) nonprofit organization under the tax identification number 13-2890727. Contributions are tax deductible to the fullest extent allowable.